Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Policy Alerts

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 8 November 1991:
Vol. 254. no. 5033, pp. 860 - 862
DOI: 10.1126/science.1948066
Prev | Table of Contents | Next

Articles

Science, Vol 254, Issue 5033, 860-862
Copyright © 1991 by American Association for the Advancement of Science

articles

Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences

L Imberti, A Sottini, A Bettinardi, M Puoti, and D Primi

Consorzio per le Biotecnologie-Consiglio Nazionale delle Ricerche-Institute of Chemistry, School of Medicine, University of Brescia, Italy.

The mechanism of T cell depletion during infection with the human immunodeficiency virus (HIV) is unclear. Examination of the repertoire of T cell receptor V (variable) regions in persons infected with HIV revealed the absence of a common set of V beta regions, whereas V alpha usage was normal. The lack of these V beta segments did not appear to correlate with opportunistic infections. The selective elimination of T cells that express a defined set of V beta sequences may indicate the presence of an HIV-encoded superantigen, similar to those encoded by the long terminal repeat of the mouse mammary tumor virus.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Distribution and Evolution of T-Cell Receptor V{beta} Repertoire on Peripheral Blood Lymphocytes of Newborn Infants of Human Immunodeficiency Virus (HIV)-Infected Mothers: Differential Display on CD4 and CD8 T Cells and Effect of HIV Infection.
W. Borkowsky, S.-H. Chen, and I. Belitskaya-Levy (2007)
Clin. Vaccine Immunol. 14, 1215-1222
   Abstract »    Full Text »    PDF »
Fine-Scale Mapping at IGAD1 and Genome-Wide Genetic Linkage Analysis Implicate HLA-DQ/DR as a Major Susceptibility Locus in Selective IgA Deficiency and Common Variable Immunodeficiency.
J. Kralovicova, L. Hammarstrom, A. Plebani, A. D. B. Webster, and I. Vorechovsky (2003)
J. Immunol. 170, 2765-2775
   Abstract »    Full Text »    PDF »
Peripheral Blood Cytotoxic {gamma}{delta} T Lymphocytes from Patients with Human Immunodeficiency Virus Type 1 Infection and AIDS Lyse Uninfected CD4+ T Cells, and Their Cytocidal Potential Correlates with Viral Load.
S. T. A. K. Sindhu, R. Ahmad, R. Morisset, A. Ahmad, and J. Menezes (2003)
J. Virol. 77, 1848-1855
   Abstract »    Full Text »    PDF »
Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects.
F. Lori, A. Foli, and J. Lisziewicz (2002)
J. Antimicrob. Chemother. 50, 155-160
   Abstract »    Full Text »    PDF »
Can Structured Treatment Interruptions (STIs) Be Used as a Strategy to Decrease Total Drug Requirements and Toxicity in HIV Infection?.
S. Walmsley and M. Loutfy (2002)
J Int Assoc Physicians AIDS Care (Chic Ill) 1, 95-103
   Abstract »    PDF »
Structured Treatment Interruptions for the Management of HIV Infection.
F. Lori and J. Lisziewicz (2001)
JAMA 286, 2981-2987
   Abstract »    Full Text »    PDF »
Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection.
S. D. Lawn, S. T. Butera, and T. M. Folks (2001)
Clin. Microbiol. Rev. 14, 753-777
   Abstract »    Full Text »    PDF »
Superantigens: The Good, the Bad, and the Ugly.
B. A. Torres, S. Kominsky, G. Q. Perrin, A. C. Hobeika, and H. M. Johnson (2001)
Experimental Biology and Medicine 226, 164-176
   Abstract »    Full Text »
Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1.
M. T. Esser, J. W. Bess Jr., K. Suryanarayana, E. Chertova, D. Marti, M. Carrington, L. O. Arthur, and J. D. Lifson (2001)
J. Virol. 75, 1152-1164
   Abstract »    Full Text »
Longitudinal analysis of T-cell receptor gene use by CD8+ T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy.
A. M. Schito, E. Vittinghoff, F. M. Hecht, M. K. Elkins, J. O. Kahn, J. A. Levy, and J. R. Oksenberg (2001)
Blood 97, 214-220
   Abstract »    Full Text »    PDF »
Resistance to Apoptosis in HIV-Infected CD4+ T Lymphocytes Is Mediated by Macrophages: Role for Nef and Immune Activation in Viral Persistence.
U. Mahlknecht, C. Deng, M. C. Lu, T. C. Greenough, J. L. Sullivan, W. A. O'Brien, and G. Herbein (2000)
J. Immunol. 165, 6437-6446
   Abstract »    Full Text »    PDF »
Prevotella intermedia Stimulates Expansion of Vbeta -Specific CD4+ T Cells.
K.-P. Leung and B. A. Torres (2000)
Infect. Immun. 68, 5420-5424
   Abstract »    Full Text »    PDF »
Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis.
G. Herbein and W. A. O'brien (2000)
Experimental Biology and Medicine 223, 241-257
   Abstract »    Full Text »
The potential importance of HIV-induction of lymphocyte homing to lymph nodes.
J. J.-Y. Chen and M. W. Cloyd (1999)
Int. Immunol. 11, 1591-1594
   Abstract »    Full Text »    PDF »
Resistance against Syncytium-Inducing Human Immunodeficiency Virus Type 1 (HIV-1) in Selected CD4+ T Cells from an HIV-1-Infected Nonprogressor: Evidence of a Novel Pathway of Resistance Mediated by a Soluble Factor(s) That Acts after Virus Entry.
K. Saha, D. J. Volsky, and E. Matczak (1999)
J. Virol. 73, 7891-7898
   Abstract »    Full Text »
Biased TCR Repertoire in HIV-1-Infected Patients Due to Clonal Expansion of HIV-1-Reverse Transcriptase-Specific CTL Clones.
W. Kolowos, M. Schmitt, M. Herrman, E. Harrer, P. Low, J. R. Kalden, and T. Harrer (1999)
J. Immunol. 162, 7525-7533
   Abstract »    Full Text »    PDF »
Human Glioma-Induced Immunosuppression Involves Soluble Factor(s) That Alters Monocyte Cytokine Profile and Surface Markers.
J.-P. Zou, L. A. Morford, C. Chougnet, A. R. Dix, A. G. Brooks, N. Torres, J. D. Shuman, J. E. Coligan, W. H. Brooks, T. L. Roszman, et al. (1999)
J. Immunol. 162, 4882-4892
   Abstract »    Full Text »    PDF »
CD4+ T-Lymphocyte Depletion in Human Lymphoid Tissue Ex Vivo Is Not Induced by Noninfectious Human Immunodeficiency Virus Type 1 Virions.
A. W. Sylwester, J.-C. Grivel, W. Fitzgerald, J. L. Rossio, J. D. Lifson, and L. B. Margolis (1998)
J. Virol. 72, 9345-9347
   Abstract »    Full Text »    PDF »
Distinct Mechanisms Trigger Apoptosis in Human Immunodeficiency Virus Type 1-Infected and in Uninfected Bystander T Lymphocytes.
G. Herbein, C. Van Lint, J. L. Lovett, and E. Verdin (1998)
J. Virol. 72, 660-670
   Abstract »    Full Text »    PDF »
Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
A. Fauci (1993)
Science 262, 1011-1018
   Abstract »    PDF »
Immunoglobulin VH3 gene products: natural ligands for HIV gp120.
L Berberian, L Goodglick, T. Kipps, and J Braun (1993)
Science 261, 1588-1591
   Abstract »    PDF »
How does HIV cause AIDS?.
R. Weiss (1993)
Science 260, 1273-1279
   Abstract »    PDF »
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
M Piatak Jr, M. Saag, L. Yang, S. Clark, J. Kappes, K. Luk, B. Hahn, G. Shaw, and J. Lifson (1993)
Science 259, 1749-1754
   Abstract »    PDF »
The Immunopathogenesis of Human Immunodeficiency Virus Infection.
G. Pantaleo, C. Graziosi, and A. S. Fauci (1993)
N. Engl. J. Med. 328, 327-335
   Full Text »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)